Top Headlines

FDA biosimilar guidance permits alternative drug delivery devices

The FDA has said biosimilars can use different drug delivery devices than their reference products in its long-awaited guidance.

Related news

News in brief

Bend Research on the hunt for more SDD alliances

Bend Research is on the lookout for more collaborative development alliances with Big Pharma through its spray-dried dispersion (SDD) technology.

Prismic hunting for anti-psychotic alliances

Prismic Pharmaceuticals is hunting for alliances to help it bring a more efficient anti-psychotic to the market after acquiring assets from drug manufacturer Scarista.

Lilly teams with Bend over spray-dried dispersion tech

Eli Lilly has licensed a spray-dried dispersion (SDD) technology from Bend Research, expanding its manufacturing capabilities.

China healthcare spending up despite economic fears, BD says

BD posted double-digit revenue growth in China as government spending on healthcare continued despite economic pressures.

Global Industry News

Catalent earnings jump as oral tech demand drives Q2 growth from Outsourcing-Pharma.com

Earnings at Catalent jumped in the second quarter as rising demand for its oral technologies offset weakness in sterile injectables.

Layoffs possible as BASi looks to cut costs after weak Q1 results from Outsourcing-Pharma.com

BASi is looking at staffing levels to “sharply” cut costs after posting first quarter results a shareholder called “pitiful”.

News in brief

Pfizer signs up Biologics Inc as cancer drug distributor from Outsourcing-Pharma.com

US-based oncology services firm Biologics Inc will distribute a kidney cancer drugs being under a new contract with Pfizer.

On your radar